Michelle J. Smith

SHIP1 Inhibition Increases Immunoregulatory Capacity and Triggers Apoptosis of Hematopoietic Cancer Cells

R. Engelman, Mi Young Park, W. Kerr, 2010, The Journal of Immunology.

Unlocking the therapeutic and commercial potential of CAR-T technology

Barbara A Nelsen, Michelle J. Smith, B. Peterson, 2016 .

T cell progenitor therapy-facilitated thymopoiesis depends upon thymic input and continued thymic microenvironment interaction.

Jason S. Mitchell, J. Tolar, K. Hogquist, 2017, JCI insight.

In Vitro T‐Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One Destination

Beau R. Webber, B. Blazar, H. Stefanski, 2015, Stem cells.

The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease

Jason S. Mitchell, D. Munn, J. Serody, 2018, The Journal of clinical investigation.

Thymic Epithelial Cell Support of Thymopoiesis Does Not Require Klotho

J. Tolar, D. Min, K. Weinberg, 2018, The Journal of Immunology.

FTY720 markedly increases alloengraftment but does not eliminate host anti-donor T cells that cause graft rejection on its withdrawal.

B. Blazar, P. Taylor, H. Stefanski, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.

H. Turnquist, Quan Liu, Gaelen K. Dwyer, 2016, Blood.

SHIP is required for a functional hematopoietic stem cell niche.

C. Desponts, W. Kerr, K. Moser, 2009, Blood.